FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...